• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Myotubularin-related protein 7 (MTMR7)

ACP09793

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP09793 Target NameMTMR7
Target Synonyms3-bisphosphate phosphatase; EC 3.1.3.-; Phosphatidylinositol-3-phosphate phosphatase; EC 3.1.3.64, MTMR7; Myotubularin-related protein 7; Inositol 1FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-660
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9Y216
Background Information
  • Uniprot Id

    Q9Y216

  • Target Species

    Human

  • Target Name

    MTMR7

  • Target Full Name

    Phosphatidylinositol-3-phosphate phosphatase MTMR7

  • Target Function

    Phosphatase that specifically dephosphorylates phosphatidylinositol 3-phosphate (PtdIns(3)P) and inositol 1,3-bisphosphate (Ins(1,3)P2).

  • Target Subcellular Location

    Cytoplasm. Endomembrane system; Peripheral membrane protein; Cytoplasmic side.

  • Target Protein Families

    Protein-tyrosine phosphatase family, Non-receptor class myotubularin subfamily

  • Target Tissue Specificity

    Expressed specifically in brain.

  • Target Research Area

    Signal Transduction

  • Target Synonyms

    MTMR7; Myotubularin-related protein 7; Inositol 1,3-bisphosphate phosphatase; EC 3.1.3.-; Phosphatidylinositol-3-phosphate phosphatase; EC 3.1.3.64

Inquire Recombinant Human Myotubularin-related protein 7 (MTMR7) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification